Showing 6971-6980 of 8690 results for "".
- Data: EpiDuo Forte Shows Benefit in Severe Inflammatory Acnehttps://practicaldermatology.com/news/data-epiduo-forte-shows-benefit-in-severe-inflammatory-acne/2458743/New data suggest that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% from Galderma, recently approved for the treatment of moderate to severe acne vulgaris, may have benefit for the topical treatment of severe inflammatory acne. Data published for the in the Dece
- Indoor Tanning Linked to Teen Substance Abusehttps://practicaldermatology.com/news/indoor-tanning-linked-to-teen-substance-abuse/2458742/New research links teen indoor tanning with substance abuse. In a study of Colorado high school students, teens who took steroids were among the most likely to use tanning beds, especially adolescent boys. Alcohol consumption in the past 30 days, marijuana use and lifetime use of select i
- Is Pregnancy-Associated Melanoma More Lethal? Study Says Yeshttps://practicaldermatology.com/news/is-pregnancy-associated-melanoma-more-lethal-study-says-yes/2458744/Women who develop melanoma during their pregnancy or within one year of it are more likely to die from the disease, a new study suggests. Specifically, women diagnosed with malignant melanoma during their pregnancy or within one year of giving birth were 5.1-times as likely to die, 6.9-ti
- Advancing Age May Affect Psoriasis Patients' Access to Biologicshttps://practicaldermatology.com/news/advancing-age-may-affect-psoriasis-patients-access-to-biologics/2458746/Elderly psoriasis patients may be less likely to receive biologics, according to a new study out of Umeå University in Sweden. Specifically, an age increase of 30 years resulted in an average 65 percent reduction in likelihood of obtaining treatment with biologics in this population
- Aclaris Therapeutics Initiates Phase 3 Clinical Trials of A-101 for the Treatment of Seborrheic Keratosishttps://practicaldermatology.com/news/aclaris-therapeutics-initiates-phase-3-clinical-trials-of-a-101-for-the-treatment-of-seborrheic-keratosis/2458748/Aclaris Therapeutics, Inc. initiated two Phase 3 clinical trials to evaluate A-101 Topical Solution for the treatment of seborrheic keratosis (SK). The two Phase 3 clinical trials will evaluate the safety and efficacy of A-101 Topical Solution comp
- Psoriasis Treatment Update: Rx Enstilar® Is Herehttps://practicaldermatology.com/news/psoriasis-treatment-update-rx-enstilaris-is-here/2458747/Enstilar®, the recently approved plaque psoriasis foam, is now available in pharmacies by prescription. Manufactured by LEO Pharma, Inc., Enstilar
- Concern About Zika Virus in US Set to Escalatehttps://practicaldermatology.com/news/concern-about-zika-virus-in-us-set-to-escalate/2458751/U.S dermatologists may start to receive calls from patients who are concerned about infection with Zika virus – particularly pregnant ones. Zika is now spreading rapidly across Latin America and the Caribbean. So far, one case has been identified in Houston, but the possibility
- Study Highlights Risk Factors for cSCC Recurrence, Metastasis and Deathhttps://practicaldermatology.com/news/study-highlights-risk-factors-for-cscc-recurrence-metastasis-and-death/2458753/Tumor depth confers the highest risk of local recurrence and metastasis of cutaneous squamous cell carcinoma (cSCC) and tumor diameter exceeding 20 mm is associated with the highest risk for disease-specific death, a new study suggests. The findings are published online in
- Almirall Exercises Call Option to Acquire ThermiGenhttps://practicaldermatology.com/news/almirall-exercises-call-option-to-acquire-thermigen/2458755/Barcelona pharma company Almirall, S.A., is stepping up their plans to take on ThermiGen LLC. The company is now exercising their call option to acquire 100 percent of the share capital of ThermiGen.
- Dermatologist Dr. Jill Waibel Selected as Keynote Speaker for Orlando Dermhttps://practicaldermatology.com/news/dermatologist-dr-jill-waibel-selected-as-keynote-speaker-for-orlando-derm/2458759/Laser expert and dermatologist Jill S. Waibel, MD, will provide the keynote speech, "Lasers for Trauma Rehabilitation: Giving Humans the Power to Heal Themselves," at the Orlando Dermatology Aesthetic and Clinical Conference (ODAC). Dr. Waibel was recently featured in national news cove